US Patent Issued to GlaxoSmithKline Intellectual Property Development on April 15 for "Processes for the production of oligonucleotides" (British Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,983, issued on April 15, was assigned to GlaxoSmithKline Intellectual Property Development Ltd. (Stevenage, Great Britain).

"Processes for the production of oligonucleotides" was invented by Andreas Crameri (Stevenage, Great Britain), Malcolm Leithhead Hill (Stevenage, Great Britain) and David Graham Tew (Stevenage, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are novel processes for the production of oligonucleotides that are suitable for use in the production of chemically modified oligonucleotides, such as those for use in therapy."

The patent was filed on March 30, 2020, under Application No. 16/833,724.

*For fu...